Proteomics/modifier based on mass spectrometry reveals the pathogenesis of eclampsia during pregnancy and the screening of disease markers

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
This article has no abstract
Epistemonikos ID: 146e8695ddc88bf413103dba8ccd161c4e74ce69
First added on: Apr 07, 2025